Status:
COMPLETED
Development of Magnetic Resonance (MR) Simulation for Treatment Planning
Lead Sponsor:
AHS Cancer Control Alberta
Collaborating Sponsors:
Cross Cancer Institute
Conditions:
Healthy
Eligibility:
All Genders
18+ years
Brief Summary
Retrospectively have access to MR images of patients to develop software that: 1. segment images 2. convert MR values to electron density and then 3. entered into a dose calculation system The proje...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subject 18 years of age and older
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00314496
Start Date
September 1 2005
End Date
November 1 2009
Last Update
February 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2